Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elif A Oral

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Med (New York, N.Y.)|March 16, 2022
Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settingsBaris Akinci, Angela Subauste, Nevin Ajluni, et al.
Clinical Endocrinology|January 27, 2021
Cardiac phenotype in familial partial lipodystrophyAbdelwahab Jalal Eldin, Baris Akinci, Andre Monteiro da Rocha, et al.
JCI Insight|July 15, 2025
Effects of FGF21, soluble TGFBR2, and environmental temperature on metabolic dysfunction in lipodystrophic miceJessica N Maung, Yang Chen, Keegan S Hoose, et al.
Cell Metabolism|July 7, 2017
Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 DiabetesElif A Oral, Shannon M Reilly, Andrew V Gomez, et al.
The Journal of Clinical Endocrinology and Metabolism|December 22, 2017
A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I MutationIram Hussain, Nivedita Patni, Masako Ueda, et al.
Annales D'Endocrinologie|August 1, 2025
Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip) Paris, France, 20-21 May 2025Camille Vatier, David Araújo-Vilar, Baris Akinci, et al.
Elife|April 18, 2017
Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expressionNuno Rocha, David A Bulger, Andrea Frontini, et al.
The Journal of Clinical Investigation|November 11, 2025
Altered lipid metabolism and inflammatory programs associate with adipocyte loss in familial partial lipodystrophy 2Jessica N Maung, Rebecca L Schill, Akira Nishii, et al.
The Journal of Clinical Endocrinology and Metabolism|February 19, 2025
Lipodystrophy Severity Score to Assess Disease Burden in LipodystrophyRebecca J Brown, Baris Akinci, Matheos Yosef, et al.
Science Translational Medicine|November 22, 2023
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiencyJudith Y Altarejos, Jeffrey Pangilinan, Simona Podgrabinska, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Med (New York, N.Y.)|March 16, 2022
Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settingsBaris Akinci, Angela Subauste, Nevin Ajluni, et al.
Clinical Endocrinology|January 27, 2021
Cardiac phenotype in familial partial lipodystrophyAbdelwahab Jalal Eldin, Baris Akinci, Andre Monteiro da Rocha, et al.
JCI Insight|July 15, 2025
Effects of FGF21, soluble TGFBR2, and environmental temperature on metabolic dysfunction in lipodystrophic miceJessica N Maung, Yang Chen, Keegan S Hoose, et al.
Cell Metabolism|July 7, 2017
Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 DiabetesElif A Oral, Shannon M Reilly, Andrew V Gomez, et al.
The Journal of Clinical Endocrinology and Metabolism|December 22, 2017
A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I MutationIram Hussain, Nivedita Patni, Masako Ueda, et al.
Annales D'Endocrinologie|August 1, 2025
Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip) Paris, France, 20-21 May 2025Camille Vatier, David Araújo-Vilar, Baris Akinci, et al.
Elife|April 18, 2017
Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expressionNuno Rocha, David A Bulger, Andrea Frontini, et al.
The Journal of Clinical Investigation|November 11, 2025
Altered lipid metabolism and inflammatory programs associate with adipocyte loss in familial partial lipodystrophy 2Jessica N Maung, Rebecca L Schill, Akira Nishii, et al.
The Journal of Clinical Endocrinology and Metabolism|February 19, 2025
Lipodystrophy Severity Score to Assess Disease Burden in LipodystrophyRebecca J Brown, Baris Akinci, Matheos Yosef, et al.
Science Translational Medicine|November 22, 2023
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiencyJudith Y Altarejos, Jeffrey Pangilinan, Simona Podgrabinska, et al.
Pageof 8